@article {17343,
	title = {Design and Development of a Viral Hepatitis and HIV Infection Screening Program (Hprolipsis) for the General, Greek Roma, and Migrant Populations of Greece: Protocol for Three Cross-Sectional Health Examination Surveys},
	journal = {JMIR Res Protoc},
	volume = {9},
	number = {1},
	year = {2020},
	note = {Touloumi, GiotaKarakosta, ArgiroSypsa, VanaPetraki, IoannaAnagnostou, OlgaTerzidis, AgisVoudouri, Niki MariaGavana, MagdaVantarakis, ApostolosRachiotis, GeorgeKantzanou, MariaRosenberg, TheofilosPapatheodoridis, GeorgeHatzakis, AngelosengCanada2020/02/01 06:00JMIR Res Protoc. 2020 Jan 31;9(1):e13578. doi: 10.2196/13578.},
	month = {Jan 31},
	pages = {e13578},
	abstract = {BACKGROUND: Although infectious diseases are globally on the decline, they remain a major global public health problem. Among them, the hepatitis B virus (HBV) or hepatitis C virus (HCV) and HIV infection are of primary interest. Valid prevalence data on these infections are sparse in Greece, especially for vulnerable populations. OBJECTIVE: This study aimed to present the design and methods of Hprolipsis, an integrated viral hepatitis and HIV screening program administered to adults (\&gt;/=18 years) from the general, Greek Roma, and migrant populations. Its aims were to estimate the prevalence of HBV, HCV, and HIV; assess infectious disease knowledge level; design, implement, and assess population-specific awareness actions; and offer individual counseling and referral when indicated and HBV vaccination to susceptible Roma and migrants. METHODS: Multistage, stratified, random sampling based on the 2011 Census was applied to select the general population sample, and nonprobability multistage quota sampling was used for Roma and migrant sample selection. Trained personnel made home (general population) or community (Roma and migrants) visits. Collected blood samples were tested for Hepatitis B surface Antigen, Hepatitis B core Antibody, Hepatitis B surface Antibody, Hepatitis C Antibody, and HIV 1,2 Antibody. The surveys were conducted during May 2013 and June 2016. To estimate an HCV prevalence of 1.5\% with 0.3 precision, the required general population sample size was estimated to be 6000. As migrants constitute 10\% of the whole Greek population, the migrant sample size was set to 600. A feasible sample size of 500 Greek Roma was set. RESULTS: In total, 6006 individuals from the general population (response rate 72\%), 534 Greek Roma, and 612 migrants were recruited. Blood test results are available for 4245 individuals from the general population, 523 Roma, and 537 migrants. CONCLUSIONS: Hprolipsis is the first nationwide survey on HBV, HCV, and HIV. Its results will enhance our understanding of the health needs and disease burden of these diseases in the 3 studied populations. Its implementation provided useful recommendations for future studies, particularly in vulnerable populations. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/13578.},
	isbn = {1929-0748 (Print)1929-0748 (Linking)},
	author = {Touloumi, G. and Karakosta, A. and Sypsa, V and Petraki, I. and Anagnostou, O. and Terzidis, A. and Voudouri, N. M. and Doctors Of The World Greek, Delegation and Gavana, M. and Vantarakis, A. and Rachiotis, G. and Kantzanou, M and Rosenberg, T. and Papatheodoridis, G. and Hatzakis, A and Hprolipsis Study, Group}
}
